Inogen Inc
$ 6.41
1.58%
05 Jun - close price
- Market Cap 173,548,000 USD
- Current Price $ 6.41
- High / Low $ 6.58 / 6.35
- Stock P/E N/A
- Book Value 6.68
- EPS -0.91
- Next Earning Report 2026-08-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.06 %
- ROE -0.13 %
- 52 Week High 9.13
- 52 Week Low 5.34
About
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other physicians, and third-party payers in the United States and internationally. The company is headquartered in Goleta, California.
Analyst Target Price
$12.67
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-02-24 | 2025-11-05 | 2025-08-07 | 2025-05-07 | 2025-02-25 | 2024-11-07 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-07 | 2023-08-07 |
| Reported EPS | -0.14 | -0.15 | -0.02 | -0.02 | -0.11 | -0.24 | -0.11 | -0.07 | -0.45 | -1.14 | -0.36 | -0.4 |
| Estimated EPS | -0.21 | -0.3424 | -0.09 | -0.09 | -0.25 | -0.49 | -0.27 | -0.39 | -0.58 | -0.62 | -0.23 | -0.6 |
| Surprise | 0.07 | 0.1924 | 0.07 | 0.07 | 0.14 | 0.25 | 0.16 | 0.32 | 0.13 | -0.52 | -0.13 | 0.2 |
| Surprise Percentage | 33.3333% | 56.1916% | 77.7778% | 77.7778% | 56% | 51.0204% | 59.2593% | 82.0513% | 22.4138% | -83.871% | -56.5217% | 33.3333% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-06 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.06 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: INGN
2026-06-05 21:08:58
Inogen Inc's Nasdaq-listed stock (INGN) has been actively trading in early June 2026, with investors reviewing its financial performance and preparing for the annual shareholder meeting. The company reported $85.1 million in revenue, a 3.4% increase driven by international growth, but continues to post net losses. Key outcomes from the AGM include the approval of directors, auditors, and executive compensation, while a proposal to declassify the board did not pass.
2026-06-04 14:39:15
Inogen Inc. has appointed three new senior leaders to drive its next phase of growth: Jason Richardson as CFO, Dominic Hulton as Chief Marketing Officer, and Corey Moritz as VP of U.S. Business to Business sales. Richardson, formerly of Baxter International, succeeds Michael Bourque, while Hulton brings over 20 years of commercial leadership from Insulet Corporation. Moritz, a healthcare executive, has a strong track record in commercial transformation and sales team building.
2026-06-03 14:39:56
Jennifer M. Yi Boyer, EVP of Inogen Inc, sold 10,770 shares of company stock for $70,313 on May 29, 2026, under a Rule 10b5-1 trading plan. The stock price has since declined, though InvestingPro analysis suggests the company is undervalued despite recent net losses. This transaction follows mixed Q1 2026 financial results where Inogen surpassed revenue expectations but missed EPS targets.
2026-06-03 14:13:51
Inogen Inc's EVP, Jennifer M. Yi Boyer, sold 10,770 shares of common stock for $70,313 on May 29, 2026, under a Rule 10b5-1 trading plan. The stock has since declined by 7.5%, though InvestingPro analysis suggests it may be undervalued. This comes after Inogen reported mixed Q1 2026 results, beating revenue expectations but missing EPS forecasts.
2026-06-02 20:09:09
Jennifer M. Yi Boyer, EVP and Chief HR Officer at Inogen Inc, sold 10,770 shares of company stock for a total of $70,313 on May 29, 2026, under a Rule 10b5-1 trading plan. Following the sale, she directly holds 15,977 shares. This comes as Inogen reported mixed Q1 2026 results with revenue surpassing expectations but EPS missing projections.
2026-06-02 20:09:09
Jennifer M. Yi Boyer, EVP Enterprise Enablement and Chief Human Resources Officer at Inogen Inc. (INGN), sold 10,770 shares of common stock on May 29, 2026. The sale, executed under a pre-arranged Rule 10b5-1 trading plan, occurred at a weighted average price of $6.5286 per share, totaling approximately $70,313. Following this transaction, Ms. Boyer directly holds 15,977 shares of Inogen common stock.
